{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:42Z","timestamp":1786979622797,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00115-017-0439-3","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T18:26:05Z","timestamp":1508783165000},"page":"1428-1434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Neues zur symptomatischen MS\u2011Therapie: Teil\u00a02 \u2013 Gangst\u00f6rung und Spastik","What is new in symptomatic MS treatment: Part\u00a02\u2014gait disorder and spasticity"],"prefix":"10.1007","volume":"88","author":[{"given":"T.","family":"Henze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Feneberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Flachenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Starck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"439_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009974","author":"B Amatya","year":"2013","unstructured":"Amatya B, Khan F, La Mantia L et\u00a0al (2013) Non pharmacological interventions for spasticity in multiple sclerosis. Cochrane Database Syst Rev. \n                        https:\/\/doi.org\/10.1002\/14651858.CD009974","journal-title":"Cochrane Database Syst Rev"},{"key":"439_CR2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jnnp.2009.177071","volume":"81","author":"JF Fleuren","year":"2010","unstructured":"Fleuren JF, Voerman GE, Erren-Wolters CV et al (2010) Stop using the Ashworth Scale for the assessment of spasticity. J\u00a0Neurol Neurosurg Psychiatry 81:46\u201352","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"439_CR3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12955-014-0119-y","volume":"12","author":"T Henze","year":"2014","unstructured":"Henze T, von Mackensen S, Lehrieder G et al (2014) Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany. Health Qual Life Outcomes 12:119","journal-title":"Health Qual Life Outcomes"},{"key":"439_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0034-1366536","volume":"82","author":"R Patejdl","year":"2014","unstructured":"Patejdl R, Tesar S, Zettl UK (2014) Multiple sclerosis, neuromyelitis optica and spasticity: control of specific symptoms and quality of life. Fortschr Neurol Psychiatr 82:373\u2013385","journal-title":"Fortschr Neurol Psychiatr"},{"key":"439_CR5","first-page":"423","volume":"46","author":"N Smania","year":"2010","unstructured":"Smania N, Picelli A, Munari D et\u00a0al (2010) Rehabilitation procedures in the management of spasticity. Eur J Phys Rehabil Med 46:423\u2013438","journal-title":"Eur J Phys Rehabil Med"},{"key":"439_CR6","volume-title":"Abnormal postural reflex activity caused by brain lesion","author":"B Bobath","year":"1985","unstructured":"Bobath B (1985) Abnormal postural reflex activity caused by brain lesion. Lippincott Williams & Wilkins, Philadelphia"},{"issue":"(Supp.1","key":"439_CR7","first-page":"2","volume":"75","author":"T Henze","year":"2004","unstructured":"Henze T, Rieckmann P, Toyka KV (2004) Symptomatische Therapie der Multiplen Sklerose. Nervenarzt 75((Supp.1):2\u201339","journal-title":"Nervenarzt"},{"key":"439_CR8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1191\/1352458503ms925oa","volume":"9","author":"I Siev-Ner","year":"2003","unstructured":"Siev-Ner I, Gamus D, Lerner-Geva L et al (2003) Reflexology treatment relieves symptoms of multiple sclerosis: a\u00a0randomized controlled study. Mult Scler 9:356\u2013361","journal-title":"Mult Scler"},{"key":"439_CR9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.clineuro.2010.03.006","volume":"112","author":"O Velikonja","year":"2010","unstructured":"Velikonja O, Curic K, Ozura A et\u00a0al (2010) Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clin Neurol Neurosurg 112:597\u2013601","journal-title":"Clin Neurol Neurosurg"},{"key":"439_CR10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.5812\/ircmj.3597","volume":"15","author":"A Ahmadi","year":"2013","unstructured":"Ahmadi A, Arastoo AA, Nikbakht M et\u00a0al (2013) Comparison of the effect of 8\u00a0weeks aerobic and yoga training on ambulatory function, fatigue and mood status in MS patients. Iran Red Crescent Med\u00a0J 15:449\u2013454","journal-title":"Iran Red Crescent Med J"},{"key":"439_CR11","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1111\/j.1365-2702.2009.02787.x","volume":"18","author":"S Ghafari","year":"2009","unstructured":"Ghafari S, Ahmadi F, Nabavi M et\u00a0al (2009) Effectiveness of applying progressive muscle relaxation technique on quality of life of patients with multiple sclerosis. J\u00a0Clin Nurs 18:2171\u20132179","journal-title":"J Clin Nurs"},{"key":"439_CR12","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.apmr.2015.05.018","volume":"96","author":"H Gunn","year":"2015","unstructured":"Gunn H, Markevics S, Haas B et\u00a0al (2015) Systematic review: the effectiveness of interventions to reduce falls and improve balance in adults with multiple sclerosis. Arch Phys Med Rehabil 96:1898\u20131912","journal-title":"Arch Phys Med Rehabil"},{"key":"439_CR13","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.apmr.2015.02.011","volume":"96","author":"M Pearson","year":"2015","unstructured":"Pearson M, Dieberg G, Smart N (2015) Exercise as a\u00a0therapy for improvement of walking ability in adults with multiple sclerosis: a\u00a0meta-analysis. Arch Phys Med Rehabil 96:1339\u20131348","journal-title":"Arch Phys Med Rehabil"},{"key":"439_CR14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neulet.2010.05.086","volume":"479","author":"JJ Sosnoff","year":"2010","unstructured":"Sosnoff JJ, Motl RW (2010) Effect of acute unloaded arm versus leg cycling exercise on the soleus H\u2011reflex in adults with multiple sclerosis. Neurosci Lett 479:307\u2013311","journal-title":"Neurosci Lett"},{"key":"439_CR15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/1352458506070663","volume":"13","author":"B Giesser","year":"2007","unstructured":"Giesser B, Beres-Jones J, Budovitch A et al (2007) Locomotor training using body weight support on a\u00a0treadmill improves mobility in persons with multiple sclerosis: a\u00a0pilot study. Mult Scler 13:224\u2013231","journal-title":"Mult Scler"},{"key":"439_CR16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2522\/ptj.20060085","volume":"87","author":"A Rampello","year":"2007","unstructured":"Rampello A, Franceschini M, Piepoli M et\u00a0al (2007) Effect of aerobic training on walking capacity and maximal exercise tolerance in patients with multiple sclerosis: a\u00a0randomized crossover controlled study. Phys Ther 87:545\u2013555","journal-title":"Phys Ther"},{"key":"439_CR17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2377-9-34","volume":"9","author":"S Coote","year":"2009","unstructured":"Coote S, Garrett M, Hogan N et\u00a0al (2009) Getting the balance right: a\u00a0randomised controlled trial of physiotherapy and exercise interventions for ambulatory people with multiple sclerosis. BMC Neurol 9:34","journal-title":"BMC Neurol"},{"key":"439_CR18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/0269215508101758","volume":"23","author":"F Schyns","year":"2009","unstructured":"Schyns F, Paul L, Finlay K et\u00a0al (2009) Vibration therapy in multiple sclerosis: a\u00a0pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clin Rehabil 23:771\u2013781","journal-title":"Clin Rehabil"},{"key":"439_CR19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1468-1331.2009.02806.x","volume":"17","author":"F Mori","year":"2010","unstructured":"Mori F, Codeca C, Kusayanagi H et\u00a0al (2010) Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis. Eur J Neurol 17:295\u2013300","journal-title":"Eur J Neurol"},{"key":"439_CR20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/1352458506071509","volume":"13","author":"L Miller","year":"2007","unstructured":"Miller L, Mattison P, Paul L et\u00a0al (2007) The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis. Mult Scler 13:527\u2013533","journal-title":"Mult Scler"},{"key":"439_CR21","doi-asserted-by":"crossref","first-page":"e103368","DOI":"10.1371\/journal.pone.0103368","volume":"9","author":"ML Linden van der","year":"2014","unstructured":"van der Linden ML, Hooper JE, Cowan P et al (2014) Habitual functional electrical stimulation therapy improves gait kinematics and walking performance, but not patient-reported functional outcomes, of people with multiple sclerosis who present with foot-drop. PLOS ONE 9:e103368","journal-title":"PLOS ONE"},{"key":"439_CR22","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1177\/1352458516643600","volume":"22","author":"S Otero-Romero","year":"2016","unstructured":"Otero-Romero S, Sastre-Garriga J, Comi G et al (2016) Pharmacological management of spasticity in multiple sclerosis: systematic review and consensus paper. Mult Scler 22:1386\u20131396","journal-title":"Mult Scler"},{"key":"439_CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1157\/13070862","volume":"124","author":"A Formica","year":"2005","unstructured":"Formica A, Verger K, Sol JM et al (2005) Gabapentin for spasticity: a\u00a0randomized, double-blind, placebo-controlled trial. Med Clin (Barc) 124:81\u201385","journal-title":"Med Clin (Barc)"},{"key":"439_CR24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1179\/016164109X12590518685660","volume":"32","author":"C Collin","year":"2010","unstructured":"Collin C, Ehler E, Waberzinek G et al (2010) A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. Neurol Res 32:451\u2013459","journal-title":"Neurol Res"},{"key":"439_CR25","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1468-1331.2010.03328.x","volume":"18","author":"A Novotna","year":"2011","unstructured":"Novotna A, Mares J, Ratcliffe S et al (2011) A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex((R)) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 18:1122\u20131131","journal-title":"Eur J Neurol"},{"key":"439_CR26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/1352458510367462","volume":"16","author":"DT Wade","year":"2010","unstructured":"Wade DT, Collin C, Stott C et al (2010) Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. Mult Scler 16:707\u2013714","journal-title":"Mult Scler"},{"issue":"656582","key":"439_CR27","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1155\/2015\/656582","volume":"2015","author":"M Russo","year":"2015","unstructured":"Russo M, Calabro RS, Naro A et al (2015) Sativex in the management of multiple sclerosis-related spasticity: role of the corticospinal modulation. Neural Plast 2015(656582):2015\u20132029. \n                        https:\/\/doi.org\/10.1155\/2015\/656582","journal-title":"Neural Plast"},{"key":"439_CR28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/jnnp-2015-312591","volume":"87","author":"F Patti","year":"2016","unstructured":"Patti F, Messina S, Solaro C et\u00a0al (2016) Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity. J\u00a0Neurol Neurosurg Psychiatry 87:944\u2013951","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"439_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1756285615612659","volume":"9","author":"UK Zettl","year":"2016","unstructured":"Zettl UK, Rommer P, Hipp P et al (2016) Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis. Ther Adv Neurol Disord 9:9\u201330","journal-title":"Ther Adv Neurol Disord"},{"key":"439_CR30","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1007\/s00415-015-7866-5","volume":"262","author":"G Coghe","year":"2015","unstructured":"Coghe G, Pau M, Corona F et\u00a0al (2015) Walking improvements with nabiximols in patients with multiple sclerosis. J\u00a0Neurol 262:2472\u20132477","journal-title":"J Neurol"},{"key":"439_CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000360285","volume":"72","author":"P Flachenecker","year":"2014","unstructured":"Flachenecker P, Henze T, Zettl UK (2014) Long-term effectiveness and safety of nabiximols (tetrahydrocannabinol\/cannabidiol oromucosal spray) in clinical practice. Eur Neurol 72:95\u2013102","journal-title":"Eur Neurol"},{"key":"439_CR32","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3109\/00207454.2013.877460","volume":"124","author":"J Koehler","year":"2014","unstructured":"Koehler J, Feneberg W, Meier M et al (2014) Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity. Int J Neurosci 124:652\u2013656","journal-title":"Int J Neurosci"},{"key":"439_CR33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/jcph.670","volume":"56","author":"D Paolicelli","year":"2016","unstructured":"Paolicelli D, Direnzo V, Manni A et al (2016) Long-term data of efficacy, safety, and tolerability in a\u00a0real-life setting of THC\/CBD oromucosal spray-treated multiple sclerosis patients. J\u00a0Clin Pharmacol 56:845\u2013851","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 1","key":"439_CR34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000444235","volume":"75","author":"MTHC Trojano","year":"2016","unstructured":"Trojano MTHC (2016) CBD observational study data: evolution of resistant MS spasticity and associated symptoms. Eur Neurol 75(Suppl 1):4\u20138","journal-title":"Eur Neurol"},{"key":"439_CR35","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ana.22240","volume":"68","author":"AD Goodman","year":"2010","unstructured":"Goodman AD, Brown TR, Edwards KR et\u00a0al (2010) A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. Ann Neurol 68:494\u2013502","journal-title":"Ann Neurol"},{"key":"439_CR36","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1177\/1352458515622695","volume":"22","author":"B Zorner","year":"2016","unstructured":"Zorner B, Filli L, Reuter K et al (2016) Prolonged-release fampridine in multiple sclerosis: improved ambulation effected by changes in walking pattern. Mult Scler 22:1463\u20131475","journal-title":"Mult Scler"},{"key":"439_CR37","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.clinthera.2012.10.003","volume":"34","author":"MD Egeberg","year":"2012","unstructured":"Egeberg MD, Oh CY, Bainbridge JL (2012) Clinical overview of dalfampridine: an agent with a\u00a0novel mechanism of action to help with gait disturbances. Clin Ther 34:2185\u20132194","journal-title":"Clin Ther"},{"key":"439_CR38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1034\/j.1600-0404.2000.101004244x.\/","volume":"101","author":"GB Orsnes","year":"2000","unstructured":"Orsnes GB, Sorensen PS, Larsen TK et\u00a0al (2000) Effect of baclofen on gait in spastic MS patients. Acta Neurol Scand 101:244\u2013248","journal-title":"Acta Neurol Scand"},{"key":"439_CR39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/0269215507072772","volume":"21","author":"M Giovannelli","year":"2007","unstructured":"Giovannelli M, Borriello G, Castri P et\u00a0al (2007) Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clin Rehabil 21:331\u2013337","journal-title":"Clin Rehabil"},{"key":"439_CR40","volume-title":"Die Behandlung der schweren Spastizit\u00e4t","author":"G Ochs","year":"1995","unstructured":"Ochs G (1995) Die Behandlung der schweren Spastizit\u00e4t. Thieme, Stuttgart"},{"key":"439_CR41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1191\/1352458506ms1232sr","volume":"12","author":"BD Smail","year":"2006","unstructured":"Smail BD, Peskine A, Roche N et\u00a0al (2006) Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients. Mult Scler 12:101\u2013103","journal-title":"Mult Scler"},{"key":"439_CR42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2340\/16501977-0811","volume":"43","author":"T Rekand","year":"2011","unstructured":"Rekand T, Gronning M (2011) Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a\u00a0long-term follow-up. J\u00a0Rehabil Med 43:511\u2013514","journal-title":"J Rehabil Med"},{"key":"439_CR43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cns.12474","volume":"22","author":"PS Rommer","year":"2016","unstructured":"Rommer PS, Kamin F, Abu-Mugheisib M et al (2016) Long-term effects of repeated cycles of Intrathecal triamcinolone acetonide on spasticity in MS patients. CNS Neurosci Ther 22:74\u201379","journal-title":"CNS Neurosci Ther"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-017-0439-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0439-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0439-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T03:07:58Z","timestamp":1512356878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-017-0439-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["439"],"URL":"https:\/\/doi.org\/10.1007\/s00115-017-0439-3","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]}}}